Authors : Sabina T, Chaarumathi A. S, Iniyavan S, Rajamoorthy S, Abinish D. G
DOI : 10.36106/gjra/0700175
Volume : 13
Issue : 9
Year : 2024
Page No : 1-4
Background: Ischemic heart disease is a critical global health issue characterized by inadequate blood supply to the myocardium, leading to an imbalance between oxygen supply and demand. This study aimed to analyze the prescription patterns of both cardiovascular and non-cardiovascular drugs among ischemic heart disease patients at a government medical college hospital in Tamil Nadu, India. Methods and Materials: This observational prospective study was conducted over six months, from April to September 2023, involving 100 patients aged 31 years and above. Data were collected during ward rounds and regular follow-ups and were analysed using Microsoft Excel 2021. Results: The study revealed that the majority of ischemic heart disease patients were aged 51 to 60 years and men had a higher predominance rate than women. The most frequently prescribed drug classes were antiplatelet agents (17.26%), antihypertensives (17%), antihyperlipidemic drugs (8.76%), anticoagulants (7.80%), and nitrates (7.18%). Additionally, noncardiovascular drugs were widely prescribed, with antacids (8.93%) and benzodiazepines (7.27%) being the most common. The prescription patterns largely adhered to established management guidelines, with a focus on antiplatelets, antihypertensives, and statins. The frequent use of non-cardiovascular drugs indicated the presence of comorbid conditions, such as gastroesophageal reux disease and anxiety. Conclusion: This study highlights the prescription patterns for ischemic heart disease and their adherence to standard management practices concluding that antiplatelets were the most commonly prescribed drugs. It also emphasizes the need for future research with larger populations and an assessment of clinical outcomes.